tiprankstipranks
Advertisement
Advertisement

HK:3378 Stock Latest News

Hanx Biopharmaceuticals Sets Board Meeting to Approve Interim 2026 Results
Company AnnouncementsHanx Biopharmaceuticals Sets Board Meeting to Approve Interim 2026 Results
6d ago
3378
PremiumCompany Announcements
Hanx Biopharmaceuticals Launches AI-Driven Drug Discovery Collaboration
1M ago
3378
Hanx Biopharmaceuticals launches AI-driven collaboration to accelerate HX009 lymphoma drug development
PremiumCompany Announcements
Hanx Biopharmaceuticals launches AI-driven collaboration to accelerate HX009 lymphoma drug development
1M ago
3378
Hanx Biopharmaceuticals Investors Voluntarily Extend Share Lock-Up Periods
PremiumCompany Announcements
Hanx Biopharmaceuticals Investors Voluntarily Extend Share Lock-Up Periods
2M ago
3378
Hanx Biopharmaceuticals AGM Backs Governance, Auditor and Profit Plan
PremiumCompany Announcements
Hanx Biopharmaceuticals AGM Backs Governance, Auditor and Profit Plan
2M ago
3378
Hanx Biopharmaceuticals Added to FTSE Global Micro Cap Index, Boosting Global Profile
PremiumCompany AnnouncementsHanx Biopharmaceuticals Added to FTSE Global Micro Cap Index, Boosting Global Profile
2M ago
3378
Hanx Biopharmaceuticals Sets 2026 AGM to Approve Results, Profit Plan and Share Mandate
Premium
Company Announcements
Hanx Biopharmaceuticals Sets 2026 AGM to Approve Results, Profit Plan and Share Mandate
2M ago
3378
Hanx Biopharmaceuticals Relocates Hong Kong Principal Office to Causeway Bay
Premium
Company Announcements
Hanx Biopharmaceuticals Relocates Hong Kong Principal Office to Causeway Bay
2M ago
3378
Hanx Biopharmaceuticals Showcases Next-Generation Cancer Drugs at 2026 AACR Meeting
PremiumCompany Announcements
Hanx Biopharmaceuticals Showcases Next-Generation Cancer Drugs at 2026 AACR Meeting
4M ago
3378
Hanx Biopharmaceuticals Showcases Next-Generation Cancer Pipeline at 2026 AACR Meeting
PremiumCompany Announcements
Hanx Biopharmaceuticals Showcases Next-Generation Cancer Pipeline at 2026 AACR Meeting
4M ago
3378
Hanx Biopharmaceuticals Deepens R&D Push as 2025 Loss Widens on Pipeline Expansion
PremiumCompany Announcements
Hanx Biopharmaceuticals Deepens R&D Push as 2025 Loss Widens on Pipeline Expansion
5M ago
3378
Hanx Biopharmaceuticals Raises Caps on Connected Raw Material Purchases
PremiumCompany Announcements
Hanx Biopharmaceuticals Raises Caps on Connected Raw Material Purchases
5M ago
3378
Hanx Biopharmaceuticals Expands Business Scope With Proposed Articles Amendments
PremiumCompany AnnouncementsHanx Biopharmaceuticals Expands Business Scope With Proposed Articles Amendments
5M ago
3378
Hanx Biopharmaceuticals Sets March Board Meeting to Approve 2025 Results and Consider Dividend
Premium
Company Announcements
Hanx Biopharmaceuticals Sets March Board Meeting to Approve 2025 Results and Consider Dividend
5M ago
3378
Hanx Biopharmaceuticals Wins Shareholder Approval for H-Share Buyback Mandate
Premium
Company Announcements
Hanx Biopharmaceuticals Wins Shareholder Approval for H-Share Buyback Mandate
6M ago
3378
Hanx Biopharmaceuticals Sets Out Board and Committee Structure
PremiumCompany Announcements
Hanx Biopharmaceuticals Sets Out Board and Committee Structure
6M ago
3378
Hanx Biopharmaceuticals Elevates Xiao Jieyu to Executive Director, Consolidating Finance and Governance Roles
PremiumCompany Announcements
Hanx Biopharmaceuticals Elevates Xiao Jieyu to Executive Director, Consolidating Finance and Governance Roles
6M ago
3378
Hanx Biopharmaceuticals Doses First Patient in First-in-Class OX40 ADC Trial
PremiumCompany Announcements
Hanx Biopharmaceuticals Doses First Patient in First-in-Class OX40 ADC Trial
6M ago
3378
Hanx Biopharmaceuticals Seeks Shareholder Mandate for Up to 10% H-Share Buyback
PremiumCompany Announcements
Hanx Biopharmaceuticals Seeks Shareholder Mandate for Up to 10% H-Share Buyback
7M ago
3378
Hanx Biopharmaceuticals Sets February 12, 2026 Extraordinary General Meeting and Book Closure
PremiumCompany AnnouncementsHanx Biopharmaceuticals Sets February 12, 2026 Extraordinary General Meeting and Book Closure
7M ago
3378
Hanx Biopharmaceuticals Ends IPO Stabilization With No Over-Allotment or Price Support Actions
Premium
Company Announcements
Hanx Biopharmaceuticals Ends IPO Stabilization With No Over-Allotment or Price Support Actions
7M ago
3378

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >